Protocol No.: MGT-GAD-025

A Randomized, Double-Blind, Sham-Controlled Study to Evaluate the Safety and Tolerability of Glutamic Acid Decarboxylase Gene Transfer to the Subthalamic Nuclei in Participants with Parkinson s Disease
Principal Investigator
Rezai, Ali
Phase
I/II
Age Group
Adult
Applicable Disease Site
Parkinson's Disease
Participating Institutions
Rockefeller Neuroscience Institute
West Virginia University
Contact
Shannon Filburn, RN, CCRC
Senior Clinical Research Specialist
Phone: +1 304-293-6736

View on ClinicalTrials.gov